<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33380/2305-2066-2021-10-4(1)-54-62</article-id><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-1101</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАЦЕВТИЧЕСКАЯ ТЕХНОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACEUTICAL TECHNOLOGY</subject></subj-group></article-categories><title-group><article-title>Прогнозирование состава таблеток с пролонгированным высвобождением на основе 4,4’-(пропандиамидо)дибензоата натрия с применением метода SeDeM</article-title><trans-title-group xml:lang="en"><trans-title>Prediction of the composition of prolonged release tablets based on 4,4'-(propandiamido) sodium dibenzoate using the SeDeM method</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9292-4240</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коцур</surname><given-names>Ю. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotsur</surname><given-names>Ju. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Коцур Юлия Михайловна</p><p>197376, Россия, г. Санкт-Петербург, ул. Проф. Попова, д. 14, лит. А</p></bio><bio xml:lang="en"><p>Julia M. Kotsur</p><p>14A, Professor Popov str., St. Petersburg, 197376, Russia</p></bio><email xlink:type="simple">uliya.kocur@spcpu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5741-4050</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ладутько</surname><given-names>Ю. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Ladytko</surname><given-names>Ju. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, Россия, г. Санкт-Петербург, ул. Проф. Попова, д. 14, лит. А</p></bio><bio xml:lang="en"><p>14A, Professor Popov str., St. Petersburg, 197376, Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5483-6626</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Наркевич</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Narkevich</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, Россия, г. Санкт-Петербург, ул. Проф. Попова, д. 14, лит. А</p></bio><bio xml:lang="en"><p>14A, Professor Popov str., St. Petersburg, 197376, Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8077-2462</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Флисюк</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Flisyuk</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, Россия, г. Санкт-Петербург, ул. Проф. Попова, д. 14, лит. А</p></bio><bio xml:lang="en"><p>14A, Professor Popov str., St. Petersburg, 197376, Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Санкт-Петербургский государственный химико-фармацевтический университет» Министерства здравоохранения Российской Федерации</institution></aff><aff xml:lang="en"><institution>Saint-Petersburg State Chemical and Pharmaceutical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>24</day><month>12</month><year>2021</year></pub-date><volume>10</volume><issue>4</issue><issue-title>Приложение 1</issue-title><fpage>54</fpage><lpage>62</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Коцур Ю.М., Ладутько Ю.М., Наркевич И.А., Флисюк Е.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Коцур Ю.М., Ладутько Ю.М., Наркевич И.А., Флисюк Е.В.</copyright-holder><copyright-holder xml:lang="en">Kotsur J.M., Ladytko J.M., Narkevich I.A., Flisyuk E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/1101">https://www.pharmjournal.ru/jour/article/view/1101</self-uri><abstract><sec><title>Введение</title><p>Введение. Технология прямого прессования является одной из наиболее распространенных технологий получения таблеток. Как известно, многие активные фармацевтические субстанции не пригодны для данной технологии без добавления специальных вспомогательных веществ. Полезным инструментом для определения пригодности порошкообразных материалов для технологии прямого прессования является метод Sediment Delivery Model (SeDeM), основанный на концепции Quality by Design. Представленный метод позволяет не только оценить пригодность материала для прямого прессования, но также помогает спрогнозировать состав твердой лекарственной формы в виде таблетки, что, в свою очередь, приводит к значительному уменьшению экспериментальных работ, проводимых при разработке нового лекарственного препарата.</p></sec><sec><title>Цель</title><p>Цель. Прогнозирование составов матричных таблеток на основе 4,4’-(пропандиамидо)дибензоата натрия с пролонгированным высвобождением, получаемых путем прямого прессования с использованием метода математического моделирования SeDeM.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Объектами исследования являлась оригинальная субстанция 4,4’-(пропандиамидо)дибензоат натрия, а также ряд вспомогательных веществ, к числу которых относились полимеры, применяемые для лекарственных форм с пролонгированным высвобождением, опудривающий компонент – стеарат магния, а также наполнитель – лактозы моногидрат. Физико-химические и технологические свойства АФС, ВВ, полученных таблеточных смесей и таблеток были изучены в соответствии с требованиями ГФ РФ XIV изд. и EP 9th ed.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Проведена оценка свойств субстанции и вспомогательных веществ в соответствии с методом SeDeM. Установлено, что субстанция 4,4’-(пропандиамидо)дибензоат натрия не пригоден для прямого прессования в связи с плохой сыпучестью и низкой прессуемостью. Гипромеллоза Methocel К4М обладала хорошей прессуемостью, однако не обладала достаточной сыпучестью. Другие исследуемые полимеры обладали удовлетворительными свойствами для осуществления технологии прямого прессования. Произведен расчет составов таблеточных смесей при помощи метода SeDeM, полученные таблеточные смеси обладали удовлетворительными технологическими характеристиками для получения таблеток путем прямого прессования. Полученные в результате эксперимента таблетки также соответствовали фармакопейным требованиям.</p></sec><sec><title>Заключение</title><p>Заключение. Проведено прогнозирование состава таблеток с пролонгированным высвобождением на основе оригинальной субстанции 4,4’-(пропандиамидо)дибензоата натрия с применением метода SeDeM. Установлено, что данный метод является пригодным для разработки состава таблеток на основе 4,4’-(пропандиамидо)дибензоата натрия.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Direct compression technology is one of the most common tablet technologies. As known, many active pharmaceutical ingredients are not suitable for this technology without the addition of special excipients. A useful tool for determining the suitability of powdered materials for direct compression technology is the Sediment Delivery Model (SeDeM) method, based on the concept of Quality by Design. The presented method allows not only to assess the suitability of a material for direct compression, but also helps to predict the composition of a solid dosage form in the form of a tablet, which, in turn, leads to a significant reduction in experimental work carried out in the development of a new drug.</p></sec><sec><title>Aim</title><p>Aim. Prediction of the compositions of matrix tablets based on sodium 4,4'-(propanediamido)dibenzoate with prolonged release, obtained by direct compression using the method of mathematical modeling SeDeM.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The objects of the study were the original substance sodium 4,4'-(propanediamido)dibenzoate, as well as a number of auxiliary substances, which included polymers used for dosage forms with prolonged release, a dusting component – magnesium stearate, and a filler – lactose monohydrate. Physicochemical and technological properties of APIs, explosives, obtained tablet mixtures and tablets were studied in accordance with the requirements of the State Pharmacopoeia of the Russian Federation XIV ed. and EP 9th ed.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The properties of the substance and excipients were assessed in accordance with the SeDeM method. It was found that the substance 4,4'-(propanediamido) sodium dibenzoate is not suitable for direct pressing due to poor flowability and low compressibility. Hypromellose Methocel K4M had good compressibility, but it did not have sufficient flowability. The other tested polymers had satisfactory properties for the direct compression technology. The composition of the tablet mixtures was calculated using the SeDeM method, the obtained tablet mixtures had satisfactory technological characteristics for obtaining tablets by direct compression. The tablets obtained as a result of the experiment also met the pharmacopoeial requirements.</p></sec><sec><title>Conclusion</title><p>Conclusion. Prediction of the composition of sustained-release tablets based on the original substance sodium 4,4'-(propanediamido)dibenzoate was carried out using the SeDeM method. It was found that this method is suitable for the development of the composition of tablets based on sodium 4,4'-(propanediamido)dibenzoate.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>прямое прессование</kwd><kwd>метод SeDeM</kwd><kwd>сыпучесть</kwd><kwd>прессуемость</kwd><kwd>таблетки с пролонгированным высвобождением</kwd><kwd>4</kwd><kwd>4’-(пропандиамидо)дибензоат натрия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>direct compression</kwd><kwd>SeDeM method</kwd><kwd>flowability</kwd><kwd>compressibility</kwd><kwd>extended release tablets</kwd><kwd>4</kwd><kwd>4'-(propanediamido)dibenzoate</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Результаты работы получены с использованием оборудования ЦКП «Аналитический центр ФГБОУ ВО СПХФУ Минздрава России» в рамках соглашения № 075-15-2021-685 от 26 июля 2021 года при финансовой поддержке Минобрнауки России</funding-statement><funding-statement xml:lang="en">The results of the work were obtained using the equipment of the Center for Collective Use "Analytical Center of Saint-Petersburg State Chemical and Pharmaceutical University" within the framework of agreement No. 075-15-2021-685 dated July 26, 2021 with the financial support of the Ministry of Education and Science of Russia</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">EMEA, 2004. Guideline on ICH Topic Q8, Note for Guidance on Pharmaceutical Development, EMEA/CHMP/167068/2004.</mixed-citation><mixed-citation xml:lang="en">EMEA, 2004. Guideline on ICH Topic Q8, Note for Guidance on Pharmaceutical Development, EMEA/CHMP/167068/2004.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Suñé Negre, J. M. Pérez Lozano P., Miñarro M., Roig M., Fuster R., Hernandez C., Ruhi R., Garcia-Montoya E., Tico J. R. Application of the SeDeM diagram and a new mathematical equation in the design of direct compression tablet formulation. European Journal of Pharmaceutics &amp; Biopharmaceutics. 2008;69:1029–1039. DOI: 10.1016/j.ejpb.2008.01.020.</mixed-citation><mixed-citation xml:lang="en">Suñé Negre, J. M. Pérez Lozano P., Miñarro M., Roig M., Fuster R., Hernandez C., Ruhi R., Garcia-Montoya E., Tico J. R. Application of the SeDeM diagram and a new mathematical equation in the design of direct compression tablet formulation. European Journal of Pharmaceutics &amp; Biopharmaceutics. 2008;69:1029–1039. DOI: 10.1016/j.ejpb.2008.01.020.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Suñé Negre J. M., Garcia-Montoya E., Pérez Lozano P., AguilarDíaz J., Roig Carreras M., Fuster R., Miñarro M., Tico J. R. SeDeM diagram: a new expert system for the formulation of drugs in solid form. Expert Systems for Human, Materials and Automation. 2011;1:17–34. DOI: 10.13140/2.1.4848.9923.</mixed-citation><mixed-citation xml:lang="en">Suñé Negre J. M., Garcia-Montoya E., Pérez Lozano P., Aguilar- Díaz J., Roig Carreras M., Fuster R., Miñarro M., Tico J. R. SeDeM diagram: a new expert system for the formulation of drugs in solid form. Expert Systems for Human, Materials and Automation. 2011;1:17–34. DOI: 10.13140/2.1.4848.9923.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nofrerias I., Nardi A., Sune-Pou M., Suñé-Negre J. M., Garcia-Montoya E., Pérez-Lozano P., Tico J. R., Miñarro M. Comparison between Microcrystalline Cellulose of different grades made by four manufacturers using SeDeM diagram expert sustem as a pharmaceutical characterization tool. Powder Technology. 2019;342:780–788. DOI: 10.1016/j.powtec.2018.10.048.</mixed-citation><mixed-citation xml:lang="en">Nofrerias I., Nardi A., Sune-Pou M., Suñé-Negre J. M., Garcia-Montoya E., Pérez-Lozano P., Tico J. R., Miñarro M. Comparison between Microcrystalline Cellulose of different grades made by four manufacturers using SeDeM diagram expert sustem as a pharmaceutical characterization tool. Powder Technology. 2019;342:780–788. DOI: 10.1016/j.powtec.2018.10.048.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sipos E., Andrea R. O., Zoltan-Istvan S., Emoke-Margit R., Gabriella Donath N. Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets. Acta Pharmaceutica. 2017:67:237–246. DOI: 10.1515/acph-2017-0017.</mixed-citation><mixed-citation xml:lang="en">Sipos E., Andrea R. O., Zoltan-Istvan S., Emoke-Margit R., Gabriella Donath N. Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets. Acta Pharmaceutica. 2017:67:237–246. DOI: 10.1515/acph-2017-0017.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nardi-Ricat A., Nofrerias-Roig I., Sune-Pou M., Pérez-Lozano P., Miñarro-Carmona M., Garcia-Montoya E., Tico-Grau J. R., Insa Boronat R., Suñé-Negre J. M. Formulation of sustained release hydrophilic matrix tablets of tolcapone with the application of SeDeM diagram: onfluence of tolcapone’s particle size on sustained release. Phrmaceutics. 2020;12(7):674. DOI: 10.3390/pharmaceutics12070674.</mixed-citation><mixed-citation xml:lang="en">Nardi-Ricat A., Nofrerias-Roig I., Sune-Pou M., Pérez-Lozano P., Miñarro-Carmona M., Garcia-Montoya E., Tico-Grau J. R., Insa Boronat R., Suñé-Negre J. M. Formulation of sustained release hydrophilic matrix tablets of tolcapone with the application of SeDeM diagram: onfluence of tolcapone’s particle size on sustained release. Phrmaceutics. 2020;12(7):674. DOI: 10.3390/pharmaceutics12070674.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kotsur Yu. M., Flisjuk E. V. Application of the SeDeM method for optimization of tablet formulations (A Review). Pharmaceutical Chemistry Journal. 2021;55:290–294. DOI: 10.1007/s11094-021-02413-0.</mixed-citation><mixed-citation xml:lang="en">Kotsur Yu. M., Flisjuk E. V. Application of the SeDeM method for optimization of tablet formulations (A Review). Pharmaceutical Chemistry Journal. 2021;55:290–294. DOI: 10.1007/s11094-021-02413-0.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hamman H., Hamman J., Wessels A., Scholtz J., Steenekamp J. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients. Pharmaceutical Development and Technology. 2019;24(2):145–156. DOI: 10.1080/10837450.2018.1435691.</mixed-citation><mixed-citation xml:lang="en">Hamman H., Hamman J., Wessels A., Scholtz J., Steenekamp J. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients. Pharmaceutical Development and Technology. 2019;24(2):145–156. DOI: 10.1080/10837450.2018.1435691.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Vasiljevic I., Turkovic E., Nenadovic S., Mirkovic M., Zimmer A., Parojcic J., Aleksic I. Investigation into liquisolid system processability based on the SeDeM Expert System approach. International Journal of Pharmaceutics. 2021;605:120847. DOI: 10.1016/j.ijpharm.2021.120847.</mixed-citation><mixed-citation xml:lang="en">Vasiljevic I., Turkovic E., Nenadovic S., Mirkovic M., Zimmer A., Parojcic J., Aleksic I. Investigation into liquisolid system processability based on the SeDeM Expert System approach. International Journal of Pharmaceutics. 2021;605:120847. DOI: 10.1016/j.ijpharm.2021.120847.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Salim I., Olowosulu A. K., Abdulsamad A., Gwarzo M. S., Khalid G. M., Ahmad N. T., Eichie F. E., Kurfi F. S. Application of SeDeM Expert System in the development of novel directly compressible co-processed excipients via co-processing. Future Journal of Pharmaceutical Sciences. 2021;7(1). DOI: 10.1186/s43094-021-00253-z.</mixed-citation><mixed-citation xml:lang="en">Salim I., Olowosulu A. K., Abdulsamad A., Gwarzo M. S., Khalid G. M., Ahmad N. T., Eichie F. E., Kurfi F. S. Application of SeDeM Expert System in the development of novel directly compressible co-processed excipients via co-processing. Future Journal of Pharmaceutical Sciences. 2021;7(1). DOI: 10.1186/s43094-021-00253-z.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Suñé-Negre J. M., Pérez-Lozano P., Miñarro M., Roig M., Fuster R., Hernandez C., Ruhi R., Garcia-Montoya E., Tico J. R. Optimization of parameters of the SeDeM Diagram Expert System: Hausner index (HI) and Relative Humidity (%RH). European Journal of Pharmaceutics &amp; Biopharmaceutics. 2011;79(2):464–472. DOI: 10.1016/j.ejpb.2011.04.002</mixed-citation><mixed-citation xml:lang="en">Suñé-Negre J. M., Pérez-Lozano P., Miñarro M., Roig M., Fuster R., Hernandez C., Ruhi R., Garcia-Montoya E., Tico J. R. Optimization of parameters of the SeDeM Diagram Expert System: Hausner index (HI) and Relative Humidity (%RH). European Journal of Pharmaceutics &amp; Biopharmaceutics. 2011;79(2):464–472. DOI: 10.1016/j.ejpb.2011.04.002</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Aguilar-Díaz J. E., Garcia-Montoya E., Pérez Lozano P., Suñé Negre J. M., Miñarro M., Tico J. R. The use of the SeDeM Diagrm expert system to determine the suitability of diluents-desintegrant for direct compression and their use in information of ODT. European Journal of Pharmaceutics &amp; Biopharmaceutics. 2009;73:414–423. DOI: 10.1016/j.ejpb.2009.07.001</mixed-citation><mixed-citation xml:lang="en">Aguilar-Díaz J. E., Garcia-Montoya E., Pérez Lozano P., Suñé Negre J. M., Miñarro M., Tico J. R. The use of the SeDeM Diagrm expert system to determine the suitability of diluents-desintegrant for direct compression and their use in information of ODT. European Journal of Pharmaceutics &amp; Biopharmaceutics. 2009;73:414–423. DOI: 10.1016/j.ejpb.2009.07.001</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bhaysar P. H., Bhatt B., Oza C., Trivedi S., Shah S. A review on: SeDeM expert system in formulation development of pharmaceutical forms. Journal of Pharmaceutical Science and Bioscientific Research. 2015;5(4):363–369.</mixed-citation><mixed-citation xml:lang="en">Bhaysar P. H., Bhatt B., Oza C., Trivedi S., Shah S. A review on: SeDeM expert system in formulation development of pharmaceutical forms. Journal of Pharmaceutical Science and Bioscientific Research. 2015;5(4):363–369.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Государственная фармакопея Российской Федерации. XIV издание. Доступно по: http://femb.ru/femb/pharmacopea.php. Ссылка активна на 14.10.2021.</mixed-citation><mixed-citation xml:lang="en">Gosudarstvennaya farmakopeya Rossiyskoy Federatsii. XIV izdaniya. [State Pharmacopoeia of the Russian Federation. XIV Edition]. Available at: http://femb.ru/femb/pharmacopea.php. Accessed: 14.10.2021. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Фармакопея Евразийского экономического союза. Доступно по: https://docs.eaeunion.org/docs/ru-ru/01426917/err_13082020_100. Ссылка активна на 14.10.2021.</mixed-citation><mixed-citation xml:lang="en">Farmakopeya Evraziyskogo ekonomicheskogo soyuza [Pharmacopoeia of the Eurasian Economic Union]. Available at: https://docs.eaeunion.org/docs/ru-ru/01426917/err_13082020_100. Accessed: 14.10.2021. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">European Pharmacopoeia. 9th edition. – Strasbourg: Council of Europe, 2016.</mixed-citation><mixed-citation xml:lang="en">European Pharmacopoeia. 9th edition. – Strasbourg: Council of Europe, 2016.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sauri J. Millam D., Suñé-Negre J., Pérez Lozano P., Sarrate R., Fabregas A., Carrilo C., Miñarro M., Tico J. R. The use of the SeDeM diagram expert system for the formulation of Captopril SR matrix tablets by direct compression. International Journal of Pharmaceutics. 2014;461;38–45. DOI: 10.1016/j.ijpharm.2013.11.029.</mixed-citation><mixed-citation xml:lang="en">Sauri J. Millam D., Suñé-Negre J., Pérez Lozano P., Sarrate R., Fabregas A., Carrilo C., Miñarro M., Tico J. R. The use of the SeDeM diagram expert system for the formulation of Captopril SR matrix tablets by direct compression. International Journal of Pharmaceutics. 2014;461;38–45. DOI: 10.1016/j.ijpharm.2013.11.029.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Aguilar-Díaz, J. E., García-Montoya E., Pérez Lozano P., Suñé-Negre J., Miñarro M., Tico J. R. SeDeM expert system a new innovator tool to develop pharmaceutical forms. Drug Development and Industrial Pharmacy. 2013;40:222–236. DOI: 10.3109/03639045.2012.756007.</mixed-citation><mixed-citation xml:lang="en">Aguilar-Díaz, J. E., García-Montoya E., Pérez Lozano P., Suñé-Negre J., Miñarro M., Tico J. R. SeDeM expert system a new innovator tool to develop pharmaceutical forms. Drug Development and Industrial Pharmacy. 2013;40:222–236. DOI: 10.3109/03639045.2012.756007.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tadwee I., Shahi S. Formulation development of losartan potassium immediate release tablets and process optimization using SeDeM expert system. Journal of Applied Pharmaceutical Science. 2018;8(2):33–43. DOI: 10.7324/JAPS.2018.8205.</mixed-citation><mixed-citation xml:lang="en">Tadwee I., Shahi S. Formulation development of losartan potassium immediate release tablets and process optimization using SeDeM expert system. Journal of Applied Pharmaceutical Science. 2018;8(2):33–43. DOI: 10.7324/JAPS.2018.8205.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Голубев А. Н., Нгуен Т. Ш., Басевич А. В., Сорокин В. В., Каухова И. Е., Марченко А. Л., Смирнова Е. М. Подходы к разработке состава таблеток с использованием современного статистического программного обеспечения и концепции Quality-byDesign. Разработка и регистрация лекарственных средств. 2019;8(3):45–48. DOI: 10.33380/2305-2066-2019-8-3-45-48.</mixed-citation><mixed-citation xml:lang="en">Golubev A. N., Nguyen T. S., Basevich A. V., Sorokin V. V., Kaukhova I. E., Marchenko A. L., Smirnova E. M. Approaches to the Development of Drugs with the Use of Modern Statistical Software Concepts and Quality-by-Design. Razrabotka i registratsiya lekarstvennykh sredstv = Drug development &amp; registration. 2019;8(3):45–48. (In Russ.) DOI: 10.33380/2305-2066-2019-8-3-45-48.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Терентьева О. А., Флисюк Е. В., Ивкин Д. Ю., Наркевич И. А. Разработка состава и технологии таблеток нового нейропротекторного средства с использованием дробного факторного эксперимента. Разработка и регистрация лекарственных средств. 2020;9(1):18–22. DOI: 10.33380/2305-2066-2020-9-1-18-22.</mixed-citation><mixed-citation xml:lang="en">Terenteva O. A., Flisyuk E. V., Ivkin D. Yu., Narkevich I. A. Development of the Composition and Technology of New Neuroprotective Drug Tablets Using Fractional Factorial Design. Razrabotka i registratsiya lekarstvennykh sredstv = Drug development &amp; registration. 2020;9(1):18–22. (In Russ.) DOI: 10.33380/2305-2066-2020-9-1-18-22.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
